Big Move For Intellia Therapeutics, Inc.
Mon, Jun 28, 2021 at 05:30 PM
Intellia Therapeutics, Inc. (NTLA:NASDAQ) rocketted at $133.43, a gain of 50.2%. On Fri, Jun 25, 2021, NTLA:NASDAQ hit a New 2-Week High of $88.83. The stock got featured on our News Catalysts scanner on Mon, Jun 28, 2021 at 03:49 PM in the 'MISCELLANEOUS' category. From Fri, Jun 11, 2021, the stock recorded 60.00% Up Days and 72.73% Green Days
The stock spiked on Fri, Jan 15, 2021 at $92 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About Intellia Therapeutics, Inc. (NTLA:NASDAQ)
Intellia Therapeutics Inc is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system.
Top 10 Gainers:
- Marin Software Incorporated (MRIN:NASDAQ), 96.85%
- QAD Inc. (QADB:NASDAQ), 79.79%
- Intellia Therapeutics, Inc. (NTLA:NASDAQ), 50.21%
- AUUD (AUUD:NASDAQ), 43.66%
- Wireless Telecom Group, Inc. (WTT:NYSEMKT), 30.89%
- New Senior Investment Group Inc. (SNR:NYSE), 29.09%
- ISPC (ISPC:NASDAQ), 25.66%
- VERV (VERV:NASDAQ), 25.03%
- JinkoSolar Holding Co., Ltd. (JKS:NYSE), 22.91%
- ENVB (ENVB:NASDAQ), 19.82%